CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
San Antonio, Texas, United States and 75 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
San Antonio, Texas, United States and 107 other locations
(maintenance) in people with systemic lupus erythematosus (lupus), infantile spasms, adults with acute relapses or flares of multiple sclerosis...
Phase 2
San Antonio, Texas, United States and 2 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
San Antonio, Texas, United States and 35 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
San Antonio, Texas, United States and 230 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
San Antonio, Texas, United States and 60 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS)....
Phase 3
San Antonio, Texas, United States and 301 other locations
Clinical trials
Research sites
Resources
Legal